Pain Management Devices Market by Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, and Ablation Devices) and Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
- ALL3757744
- 213 Pages
- January 2020
- Healthcare
Pain management devices are medical devices, which are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, and musculoskeletal pain. Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are different forms of pain management devices available in the market.
Significant increase in prevalence of chronic pain, rise in geriatric population, surge in awareness among people toward pain management devices, and increase in demand for pain management devices in developing region are the key factors that fuel the growth of the market. Moreover, availability of innovative pain management devices, surge in R&D activities to develop technologically advanced pain management devices, increase in availability of lower cost portable products, and development of the medical device industry across the globe are other factors that contribute toward the growth of the market. However, hypersensitivity reactions and post-operative infections caused due to the use these devices limit their adoption. Moreover, they are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which hinders the growth of the market.
The pain management devices market is segmented into type, application, and region. By type, the market is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. Depending on application, it is classified into cancer pain, neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product Type
• Neuromodulation & Neurostimulation devices
• Analgesic Infusion Pumps
• Ablation Devices
By Application
• Neuropathic Pain
• Cancer Pain
• Facial & Migraine Pain
• Musculoskeletal Pain
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Abbott Laboratories
• B Braun Melsungen AG
• Baxter International Inc.
• Boston Scientific Corp
• DJO Global LLC
• Johnson & Johnson (Codman And Shurtleff, Inc,)
• Kimberly Clark Corporation
• Medtronic Plc
• Pfizer, Inc.
• Stryker Corp.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• Halyard Health, Inc.
• Neurotech NA, Inc.
• Nevro Corp
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Market player positioning, 2018
3.3. Porter’s five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic disease
3.4.1.2. Rise in in geriatric population
3.4.1.3. Increase in adoption of pain management devices
3.4.2. Restraint
3.4.2.1. Preferable use of medications for pain management
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.4. Impact analysis
CHAPTER 4: PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Neuromodulation & Neurostimulation devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Spinal cord stimulators
4.2.2.1.1. Market size and forecast
4.2.2.2. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
4.2.2.2.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Analgesic Infusion Pumps
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. External infusion pumps
4.3.2.1.1. Market size and forecast
4.3.2.2. Intrathecal Infusion Pumps
4.3.2.2.1. Market size and forecast
4.3.3. Market size and forecast
4.3.4. Market analysis, by country
4.4. Ablation Devices
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Neuropathic pain
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Cancer pain
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Facial & migraine pain
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Musculoskeletal pain
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Others
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
CHAPTER 6: PAIN MANAGEMENT DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. pain management devices market, by product type
6.2.2.1.2. U.S. pain management devices market, by application
6.2.2.2. Canada
6.2.2.2.1. Canada pain management devices market, by product type
6.2.2.2.2. Canada pain management devices market, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico pain management devices market, by product type
6.2.2.3.2. Mexico pain management devices market, by application
6.2.3. North America market size and forecast, by product type
6.2.4. North America pain management devices market, by application
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany pain management devices market, by product type
6.3.2.1.2. Germany pain management devices market, by application
6.3.2.2. France
6.3.2.2.1. France pain management devices market, by product type
6.3.2.2.2. France pain management devices market, by application
6.3.2.3. UK
6.3.2.3.1. UK pain management devices market, by product type
6.3.2.3.2. UK pain management devices market, by application
6.3.2.4. Italy
6.3.2.4.1. Italy pain management devices market, by product type
6.3.2.4.2. Italy pain management devices market, by application
6.3.2.5. Spain
6.3.2.5.1. Spain pain management devices market, by product type
6.3.2.5.2. Spain pain management devices market, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe pain management devices market, by product type
6.3.2.6.2. Rest of Europe pain management devices market, by application
6.3.3. Europe market size and forecast, by product type
6.3.4. Europe pain management devices market, by application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan pain management devices market, by product type
6.4.2.1.2. Japan pain management devices market, by application
6.4.2.2. China
6.4.2.2.1. China pain management devices market, by product type
6.4.2.2.2. China pain management devices market, by application
6.4.2.3. Australia
6.4.2.3.1. Australia pain management devices market, by product type
6.4.2.3.2. Australia pain management devices market, by application
6.4.2.4. India
6.4.2.4.1. India pain management devices market, by product type
6.4.2.4.2. India pain management devices market, by application
6.4.2.5. South Korea
6.4.2.5.1. South Korea pain management devices market, by product type
6.4.2.5.2. South Korea pain management devices market, by application
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific pain management devices market, by product type
6.4.2.6.2. Rest of Asia-Pacific pain management devices market, by application
6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific pain management devices market, by application
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil pain management devices market, by product type
6.5.2.1.2. Brazil pain management devices market, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia pain management devices market, by product type
6.5.2.2.2. Saudi Arabia pain management devices market, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa pain management devices market, by product type
6.5.2.3.2. South Africa pain management devices market, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA pain management devices market, by product type
6.5.2.4.2. Rest of LAMEA pain management devices market, by application
6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA pain management devices market, by application
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. B Braun Melsungen Ag
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. BAXTER INTERNATIONAL INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. Boston Scientific Corporation
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. DJO Global LLC
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. Johnson & Johnson (Codman and Shurtleff, Inc.,)
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Kimberly-Clark Corporation (Baylis Medical)
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Medtronic Plc
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Pfizer Inc. (Hospira Inc.)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Stryker Corporation
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
TABLE 01. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 02. NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 03. NEUROMODULATION & NEUROSTIMULATION DEVICES PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. ANALGESIC INFUSION PUMPS MARKET, BY TYPE, 2018–2026, ($MILLION)
TABLE 05. ANALGESIC INFUSION PUMPS PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 06. ABLATION DEVICES PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 07. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 08. PAIN MANAGEMENT DEVICES MARKET FOR NEUROPATHIC PAIN, BY REGION, 2018–2026 ($MILLION)
TABLE 09. PAIN MANAGEMENT DEVICES MARKET FOR CANCER PAIN, BY REGION, 2018–2026 ($MILLION)
TABLE 10. PAIN MANAGEMENT DEVICES MARKET FOR FACIAL & MIGRAINE PAIN, BY REGION, 2018–2026 ($MILLION)
TABLE 11. PAIN MANAGEMENT DEVICES MARKET FOR MUSCULOSKELETAL PAIN, BY REGION, 2018–2026 ($MILLION)
TABLE 12. PAIN MANAGEMENT DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 13. PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 15. U.S. PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 16. U.S. PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 17. CANADA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 18. CANADA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 19. MEXICO PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 20. MEXICO PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 21. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 22. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 23. EUROPE PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 24. GERMANY PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 25. GERMANY PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 26. FRANCE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 27. FRANCE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 28. UK PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 29. UK PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 30. ITALY PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 31. ITALY PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 32. SPAIN PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 33. SPAIN PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 34. REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 35. REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 36. EUROPE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 37. EUROPE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 38. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 39. JAPAN PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 40. JAPAN PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 41. CHINA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 42. CHINA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 43. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 44. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 45. INDIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 46. INDIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 47. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 48. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 49. REST OF ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 50. REST OF ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 51. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 52. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 53. LAMEA PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 54. BRAZIL PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 55. BRAZIL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 56. SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 57. SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 58. SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 59. SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 60. REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 61. REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 62. LAMEA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 63. LAMEA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 64. ABBOTT: COMPANY SNAPSHOT
TABLE 65. ABBOTT: OPERATING SEGMENTS
TABLE 66. ABBOTT: PRODUCT PORTFOLIO
TABLE 67. B BRAUN: COMPANY SNAPSHOT
TABLE 68. B BRAUN: OPERATING SEGMENTS
TABLE 69. B BRAUN: PRODUCT PORTFOLIO
TABLE 70. BAXTER: COMPANY SNAPSHOT
TABLE 71. BAXTER: OPERATING SEGMENTS
TABLE 72. BAXTER: PRODUCT PORTFOLIO
TABLE 73. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 74. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 75. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 76. DJO: COMPANY SNAPSHOT
TABLE 77. DJO: OPERATING SEGMENTS
TABLE 78. DJO: PRODUCT PORTFOLIO
TABLE 79. J&J: COMPANY SNAPSHOT
TABLE 80. J&J: OPERATING SEGMENTS
TABLE 81. J&J: PRODUCT PORTFOLIO
TABLE 82. KIMBERLY-CLARK: COMPANY SNAPSHOT
TABLE 83. KIMBERLY-CLARK: OPERATING SEGMENTS
TABLE 84. KIMBERLY-CLARK: PRODUCT PORTFOLIO
TABLE 85. MEDTRONIC: COMPANY SNAPSHOT
TABLE 86. MEDTRONIC: OPERATING SEGMENTS
TABLE 87. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88. PFIZER INC.: COMPANY SNAPSHOT
TABLE 89. PFIZER INC.: OPERATING SEGMENTS
TABLE 90. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 91. STRYKER: COMPANY SNAPSHOT
TABLE 92. STRYKER: OPERATING SEGMENTS
TABLE 93. STRYKER: PRODUCT PORTFOLIO
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
